Oncologix Tech, Inc. is a medical holding company, which is engaged in the operation and manufacture of medical device products. The company is headquartered in Kentwood, Michigan. The firm has been engaging manufacturers and stakeholders in the industry both in the United States and South Korea to execute agreements with partners, customers, vendors, and manufacturers, reviewing licenses and sublicense agreements with potential licensors, interviewing and hiring employees, and conducting research and due diligence on potential partners, joint-ventures, and acquisitions in the biotech industry. The firm is also seeking additional acquisitions of diagnostic and biotechnology opportunities.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
08/31/2014
08/31/2013
08/31/2012
08/31/2011
08/31/2010
Revenue
4
3
0
0
0
0
Revenue Growth (YoY)
100%
--
--
--
--
--
Cost of Revenue
3
3
0
--
--
0
Gross Profit
0
0
0
--
--
0
Selling, General & Admin
1
1
0
0
0
0
Research & Development
0
0
--
--
--
--
Operating Expenses
1
1
0
0
0
0
Other Non Operating Income (Expenses)
0
0
0
0
0
0
Pretax Income
-1
-1
0
0
0
0
Income Tax Expense
--
0
0
0
0
0
Net Income
-1
-1
0
0
0
0
Net Income Growth
0%
--
--
--
--
-100%
Shares Outstanding (Diluted)
242.58
102.55
61.86
54.44
47.91
45.64
Shares Change (YoY)
115.99%
66%
14%
14%
5%
41%
EPS (Diluted)
-0.01
-0.01
-0.01
0
0
-0.01
EPS Growth
-53%
28.99%
104%
6%
-70%
-79%
Free Cash Flow
0
0
0
0
0
0
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
0%
0%
0%
--
--
0%
Operating Margin
0%
0%
0%
0%
0%
0%
Profit Margin
-25%
-33.33%
0%
0%
0%
0%
Free Cash Flow Margin
0%
0%
0%
0%
0%
0%
EBITDA
0
0
0
0
0
0
EBITDA Margin
0%
0%
0%
0%
0%
0%
D&A For EBITDA
0
0
0
0
0
0
EBIT
0
0
0
0
0
0
EBIT Margin
0%
0%
0%
0%
0%
0%
Effective Tax Rate
--
0%
0%
0%
0%
0%
Follow-Up Questions
What are Oncologix Tech Inc's key financial statements?
According to the latest financial statement (Form-10K), Oncologix Tech Inc has a total asset of $2, Net loss of $-1
What are the key financial ratios for OCLG?
Oncologix Tech Inc's Current ratio is 1, has a Net margin is -33.33, sales per share of $0.02.
How is Oncologix Tech Inc's revenue broken down by segment or geography?
Oncologix Tech Inc largest revenue segment is Films, at a revenue of 166,842,000,000 in the most earnings release.For geography, Japan is the primary market for Oncologix Tech Inc, at a revenue of 253,491,000,000.
Is Oncologix Tech Inc profitable?
no, according to the latest financial statements, Oncologix Tech Inc has a net loss of $-1
Does Oncologix Tech Inc have any liabilities?
yes, Oncologix Tech Inc has liability of 2
How many outstanding shares for Oncologix Tech Inc?
Oncologix Tech Inc has a total outstanding shares of 134.6